StreetAlpha
13F holdings · Q3 2026

Rtw Investments

New York, NY · files as Rtw Investments, LP
Know the moment Rtw Investments filesYou follow Rtw Investments An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1493215

Rtw Investments reported 83 stocks worth $9.9B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are PTGX (7.2%), ARGX (6.9%) and CGON (6.1%). Compared with Q2 2026, the fund opened new positions in VRDN, KRSA and PYXS, added to ARGX, IRTC and TNGX, trimmed INSM, SYRE and RDNT and sold out of ALKS, DFTX and IDYA.

Latest filing: what Rtw Investments did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
12 new19 added12 trimmed13 sold outBought about $634M · sold about $2B
New 12
See all 12 →
Added 19
See all 19 →
Trimmed 12
See all 12 →
Sold out 13
See all 13 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$9.9B−15.3% vs last quarter
Stocks held8312 new · 13 sold out
Top 5 weight27.3%spread out
Turnover26%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
PTGX
Protagonist Therapeutics Inc
$713M7.2%5.1MNo change8 of 8
2
ARGX
Argenx SE
$682M6.9%712K+2,138 (+0%)8 of 8
3
CGON
CG Oncology Inc
$604M6.1%8.5MNo change8 of 8
4
IRTC
Irhythm Technologies Inc
$354M3.6%3.1M+936K (+43%)4 of 8
5
INSM
Insmed Inc
$353M3.6%3.1M−1.7M (−36%)8 of 8
6
TNGX
Tango Therapeutics Inc
$351M3.5%14M+148K (+1%)4 of 8
7
ERAS
Erasca Inc
$329M3.3%22.4M+4.5M (+25%)4 of 8
8
SYRE
Spyre Therapeutics Inc
$329M3.3%3.7M−560K (−13%)8 of 8
9
RDNT
Radnet Inc
$319M3.2%4.6M−216K (−4%)8 of 8
10
TARS
Tarsus Pharmaceuticals Inc
$274M2.8%3.5M+127K (+4%)8 of 8
🔒 73 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
ALKS
Alkermes PLC
$87.6M1.7M
DFTX
Definium Therapeutics Inc
$18.8M400K
IDYA
Ideaya Biosciences Inc
$13.8M370K
ATAI BECKLEY NV
$10.5M2M
TENX
Tenax Therapeutics Inc
$10.1M697K

🔒 Free account: see all 13.

Reported value

last 8 quarters
$6.6BQ4 '24
$6.5BQ1 '25
$7BQ2 '25
$8.1BQ3 '25
$10BQ4 '25
$10BQ1 '26
$11.7BQ2 '26
$9.9BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Rtw Investments 13F FAQ

What does Rtw Investments own?

Rtw Investments reported 83 stocks worth $9.9B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are PTGX (7.2%), ARGX (6.9%) and CGON (6.1%). The table above lists every position in the filing (the top 10 without an account).

What did Rtw Investments buy and sell in Q3 2026?

Compared with Q2 2026: 12 new positions, 19 added to, 12 trimmed and 13 sold out. New positions include VRDN, KRSA and PYXS. It sold all of ALKS, DFTX and IDYA.

When will Rtw Investments file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Rtw Investments's portfolio worth?

The Q3 2026 filing reports $9.9B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.